Zacks Small Cap Research – AZTR: New Site for ATR-04 Trial
By John Vandermosten, CFA NYSE:AZTR READ THE FULL AZTR RESEARCH REPORT Azitra, Inc. (NYSE:AZTR) reported full year 2025 financial and operational results in a February 27thpress release and provided a business update. Since our previous quarterly dispatch in November, Azitra has announced a new, world-class cancer center site for the ATR-04 program, attended several investor […]